Table of Content

  1. INTRODUCTION
    1. Study Assumptions and Market Definition
    2. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. Higher Regulatory Scrutiny & Demand for Safety Assessment of Products
    3. Market Restraints
      1. Inefficiency of In-vivo Genotoxicity Testing Methods
    4. Market Opportunity
      1. Increasing Demand for Genetic Toxicity Assessment Within the Growing Field of Personalized Medicine
    5. Market Trends
      1. Shift Towards In-Vitro Methods
      2. Integration of Artificial Intelligence
  5. MARKET SEGMENTATION
    1. By Product
      1. Reagents & Consumables
      2. Assays
      3. Services
    2. By Application
      1. Healthcare (Pharmaceutical & Biotechnology)
      2. Food
      3. Cosmetics
      4. Others (Chemicals & Agriculture)
    3. By Key Geographic Regions
      1. North America
        1. United States
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profile
      1. Charles River Laboratories International, Inc.
      2. Eurofins Scientific
      3. Gentronix Limited
      4. Jubilant Life Sciences Limited
      5. Laboratory Corp of America Holdings
      6. Merck KGaA
      7. Thermo Fisher Scientific, Inc.
      8. Toxikon Corporation

7. MARKET OPPORTUNITIES AND FUTURE TRENDS



Frequently Asked Questions

Q.1. What is the projected market value of the global Genetic Toxicity Testing market?

The global market of genetic toxicity testing is projected to reach USD 4.75 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Genetic Toxicity Testingmarket?

The global genetic toxicity testing market has an estimated annual growth rate of 10.2% .

Q.3. What are the recent trends of Genetic Toxicity Testingmarket?

Shift towards in-vitro methods as well as integration of Artificial Intelligenceare some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Genetic Toxicity Testing?

The major companies profiled in this report include Charles River Laboratories International, Inc., Eurofins Scientific, Gentronix Limited, Jubilant Life Sciences Limited, Laboratory Corp of America Holdings, Merck KGaA, Thermo Fisher Scientific, Inc., Toxikon Corporation, among others.

Q.5. Which is the largest regional market in the Genetic Toxicity Testing?

North America is the largest regional market for Genetic Toxicity Testing.

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.